1 / 4

Report from ATOME Meeting in Cyprus

Explore the societal impact of controlled medicines at the ATOME meeting in Cyprus, focusing on opioid analgesics and policy reviews for improved access. Learn about the WHO programme's initiatives since 2007 and the ATOME consortium's work across Europe and target countries.

buttram
Download Presentation

Report from ATOME Meeting in Cyprus

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Report from ATOME Meeting in Cyprus Willem Scholten, PharmD, MPA Team Leader, Access to Controlled Medicines, World Health Organization, Geneva, Switzerland +41 22 79 15540 scholtenw@who.int 30 May, 2012 Societal Impact of Pain 2012, Copenhagen Directly from The Classic Hotel, Nicosia, Cyprus

  2. Access to Controlled Medicines Programme • WHO Programme since 2007 • All controlled medicines: • Opioid analgesics (e.g. morphine) • Long-acting opioids for treatment of heroin dependence (e.g. methadone) • Other (anti-epileptics, anxyolitics, obstetric medicines) • Small team – volunteers and interns • Beyond October 2012 ?

  3. ATOME • Access to Opioid Medicines in Europe • Consortium of 10 partners • Legislation and policy review for access to opioids • Working with the countries • Now "national conference" to generate critical mass • Reports to MoHs in 2014

  4. ATOME Target Countries

More Related